Evidence map›Paper›PMID 30400250›Full record

ArticleMarine drugs2018

Influence of Preparation Methods of Chitooligosaccharides on Their Physicochemical Properties and Their Anti-Inflammatory Effects in Mice and in RAW264.7 Macrophages.

Ángela Sánchez, María Mengíbar, Margarita Fernández, Susana Alemany, Angeles Heras, Niuris Acosta

Abstract read
In one paragraph

Article in Marine drugs, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Relaxin in fibrotic ligament diseases: Its regulatory role and mechanism.Frontiers in cell and developmental biology · 2023
    Review
  6. ExploringInternational journal of molecular sciences · 2022
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Immunomodulatory Effects ofMarine drugs · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ángela SánchezInstituto de Estudios Biofuncionales, Departamento de Química en Ciencias Farmacéuticas, Facultad de Farmacia, Universidad Complutense de Madrid, 28040 Madrid, Spain. assanchez@iib.uam.es.ORCID 0000-0002-8859-432X
María MengíbarInstituto de Estudios Biofuncionales, Departamento de Química en Ciencias Farmacéuticas, Facultad de Farmacia, Universidad Complutense de Madrid, 28040 Madrid, Spain. marianmengibar@hotmail.es.
Margarita FernándezInstituto de Investigaciones Biomédicas "Alberto Sols", Consejo Superior de Investigaciones Científicas & Universidad Autónoma de Madrid, (CSIC-UAM) 28029 Madrid, Spain. marfermar47@gmail.com.
Susana AlemanyInstituto de Investigaciones Biomédicas "Alberto Sols", Consejo Superior de Investigaciones Científicas & Universidad Autónoma de Madrid, (CSIC-UAM) 28029 Madrid, Spain. salemany@iib.uam.es.
Angeles HerasInstituto de Estudios Biofuncionales, Departamento de Química en Ciencias Farmacéuticas, Facultad de Farmacia, Universidad Complutense de Madrid, 28040 Madrid, Spain. aheras@ucm.es.
Niuris AcostaInstituto de Estudios Biofuncionales, Departamento de Química en Ciencias Farmacéuticas, Facultad de Farmacia, Universidad Complutense de Madrid, 28040 Madrid, Spain. facosta@ucm.es.ORCID 0000-0001-5145-8781

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The methods to obtain chitooligosaccharides are tightly related to the physicochemical properties of the end products. Knowledge of these physicochemical characteristics is crucial to describing the biological functions of chitooligosaccharides. Chitooligosaccharides were prepared either in a single-step enzymatic hydrolysis using chitosanase, or in a two-step chemical-enzymatic hydrolysis. The hydrolyzed products obtained in the single-step preparation were composed mainly of 42% fully deacetylated oligomers plus 54% monoacetylated oligomers, and they attenuated the inflammation in lipopolysaccharide-induced mice and in RAW264.7 macrophages. However, chitooligosaccharides from the two-step preparation were composed of 50% fully deacetylated oligomers plus 27% monoacetylated oligomers and, conversely, they promoted the inflammatory response in both in vivo and in vitro models. Similar proportions of monoacetylated and deacetylated oligomers is necessary for the mixtures of chitooligosaccharides to achieve anti-inflammatory effects, and it directly depends on the preparation method to which chitosan was submitted.

Indexed as

AnimalsAnti-Inflammatory AgentsChitinChitosanDisease Models, AnimalGlycoside HydrolasesHumansHydrolysisInflammationLipopolysaccharidesMiceMice, Inbred C57BLMolecular StructureOligosaccharidesRAW 264.7 CellsStructure-Activity RelationshipAnti-Inflammatory AgentsChitinChitosanchitosanaseGlycoside HydrolasesLipopolysaccharidesoligochitosanOligosaccharidesanti-inflammatory actionchitooligosaccharidesRAW264.7 macrophage

Identifiers

PMID30400250
PMCPMC6265923

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.